Eliminating hypoxic tumor cells improves response to PARP inhibitors in homologous recombination–deficient cancer models-Reference-Cited by-同舟云学术

Eliminating hypoxic tumor cells improves response to PARP inhibitors in homologous recombination–deficient cancer models

Published:2021-06-01 Issue:11 Volume:131 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Mehibel Manal,Xu Yu^ORCID,Li Caiyun G.,Moon Eui Jung,Thakkar Kaushik N.,Diep Anh N.,Kim Ryan K.,Bloomstein Joshua D.,Xiao Yiren,Bacal Julien,Saldivar Joshua C.,Le Quynh-Thu^ORCID,Cimprich Karlene A.,Rankin Erinn B.,Giaccia Amato J.

Funder

NIH Clinical Center

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/146256/files/pdf

Reference68 articles.

1. Targeting tumour-supportive cellular machineries in anticancer drug development

2. The Concept of Synthetic Lethality in the Context of Anticancer Therapy

3. Targeting DNA Repair in Cancer: Beyond PARP Inhibitors

4. PARP inhibitors: Synthetic lethality in the clinic

5. Structural Basis of Detection and Signaling of DNA Single-Strand Breaks by Human PARP-1

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia‐Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively Eradicates Treatment‐Resistant Cancer Cells;Advanced Science;2024-07-08

2. Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours;Frontiers in Oncology;2024-01-30

3. Mechanism of PARP inhibitor resistance and potential overcoming strategies;Genes & Diseases;2024-01

4. Exploiting the DNA Damage Response for Prostate Cancer Therapy;Cancers;2023-12-23

5. In VitroCharacterization of the Bacteria-derived Hypoxia-selective Cytotoxin BE-43547;Anticancer Research;2023-11-29